{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihadpgwce3l77am7c7paacovygpn7fvwn3huylca4pm5d6duc6ttm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjgfdydz35f2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic632w2cml5sbydbjrt3eniprawl7f26s6ayd3rm5el7ywqnf536q"
    },
    "mimeType": "image/jpeg",
    "size": 37967
  },
  "path": "/pharmalot/2026/04/13/maryland-affordability-board-sets-first-price-cap-diabetes-medicine/?utm_campaign=rss",
  "publishedAt": "2026-04-14T01:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "biotechnology",
    "drug pricing",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.",
  "title": "STAT+: Maryland state affordability board sets its first price cap for a medicine",
  "updatedAt": "2026-04-14T01:39:44.000Z"
}